Key result
N-Propargyl caffeate amide (PACA) attenuated isoproterenol-induced cardiac fibrosis in rats and promoted a phenotypic switch of macrophages towards a pro-resolving M2a-like phenotype via covalent binding to PPAR-γ.
Why the study?
Because macrophages control cardiac fibrosis during post-infarction remodeling, this study investigated whether N-propargyl caffeate amide (PACA) could suppress myocardial fibrosis by regulating macrophage polarization.
PACA attenuates cardiac fibrosis in a rat model of myocardial infarction by promoting pro-resolving macrophage polarization via the PPAR-γ pathway.
Answers are grounded in this paper and cite their sources.
Does not support clinical use; leaves open translation of PACA to human cardiac fibrosis via PPAR-γ.
Macrophages control the initiation and resolution of cardiac fibrosis in post-infarction cardiac remodeling. The aim of the present study was to investigate whether N-propargyl caffeate amide (PACA) could suppress myocardial fibrosis via regulating macrophage polarization. By using rat model of isoproterenol-induced myocardial fibrosis, we discovered that PACA could reduce cardiac fibrosis in a dose-dependent manner. To elucidate the anti-fibrotic mechanisms, we examined whether PACA affected pro-inflammatory M1 and pro-resolving macrophage biomarkers in macrophage polarization. As result, PACA reduced the expression of pro-inflammatory M1 biomarkers (e.g., iNOS, TNF-α, CXCL10, IL-6, CCL2 and CD80) while increased the expression of pro-resolving M2a biomarkers (e.g., IL-10, arginase-1, FZZ1, YM-1 and CD163) in LPS-stimulated RAW264.7 macrophages. PACA also suppressed the elevation of M1 biomarker ED1 in the early phase but up-regulated the expression of pro-resolving biomarker ED2 in the later phase. Moreover, PACA reduced the expression of pro-fibrotic TGF-β1 and PDGF-α while maintained or even increased the production of pro-apoptotic MMP-13, MMP-9 and TRAIL. Importantly, mechanistic studies revealed that PACA might promote the switch of macrophage polarization towards a pro-resolving macrophage phenotype via activating PPAR-γ pathway. Taken together, this study suggested that PACA might be a drug candidate for preventing cardiac fibrosis in myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2020) studied Cardiac fibrosis in myocardial infarction. N-Propargyl caffeate amide (PACA) vs. Isoproterenol alone (vehicle) was evaluated on Cardiac fibrosis and macrophage polarization. N-Propargyl caffeate amide (PACA) attenuated isoproterenol-induced cardiac fibrosis in rats and promoted a phenotypic switch of macrophages towards a pro-resolving M2a-like phenotype via covalent binding to PPAR-γ.
Synapse has enriched 10 related papers. Consider them for comparative context: